FuturHealth exists to fill this void with a modern, digital-first approach that respects the complexities of weight loss and empowers people to move forward with confidence
Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L
This has led to concerns over the sources of compounded semaglutide and the use of different formulations, such as semaglutide sodium
Minimal Side Effects: Designed to reduce undesirable side effects with minimal impact on cortisol and prolactin levels
"But there will come a day when we no longer see these access barriers for GLP-1s." Copyright 2026 NPR
Key drivers behind GLP-1 and addiction research include: Rapid expansion in the use of GLP-1 medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Maunjaro and Zepbound) Reports of changes in cravings, alcohol use, or reward-seeking behaviors beyond weight loss Increased public conversation and clinical curiosity about psychological and behavioral effects Scientific interest in GLP-1 activity within reward pathways and dopamine signaling Recognition that appetite regulation and addiction involve shared neural mechanisms This research is still emerging, and findings should be interpreted with caution